NYSE:NGVT - Ingevity Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $114.28 +0.27 (+0.24 %) (As of 02/22/2019 01:30 PM ET)Previous Close$114.01Today's Range$112.89 - $115.2852-Week Range$70.71 - $120.41Volume179,951 shsAverage Volume234,267 shsMarket Capitalization$4.80 billionP/E Ratio27.67Dividend YieldN/ABeta1.55 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process. This segment's products are used in various applications comprising asphalt paving, oilfield exploration and production, printing inks, adhesives, agrochemical dispersants, lubricants, and other diverse industries. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina. Receive NGVT News and Ratings via Email Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:NGVT Previous SymbolNASDAQ:NGVT CUSIPN/A CIK1653477 Webwww.ingevity.com Phone843-740-2300Debt Debt-to-Equity Ratio2.18 Current Ratio2.31 Quick Ratio1.26Price-To-Earnings Trailing P/E Ratio27.67 Forward P/E Ratio23.47 P/E Growth2 Sales & Book Value Annual Sales$1.13 billion Price / Sales4.23 Cash Flow$5.8605 per share Price / Cash Flow19.50 Book Value$8.09 per share Price / Book14.13Profitability EPS (Most Recent Fiscal Year)$4.13 Net Income$169.10 million Net Margins14.92% Return on Equity53.15% Return on Assets13.60%Miscellaneous Employees1,500 Outstanding Shares41,970,000Market Cap$4.80 billion Next Earnings Date5/1/2019 (Estimated) OptionableOptionable Ingevity (NYSE:NGVT) Frequently Asked Questions What is Ingevity's stock symbol? Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT." How were Ingevity's earnings last quarter? Ingevity Corp (NYSE:NGVT) posted its earnings results on Wednesday, February, 13th. The company reported $1.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.78 by $0.29. The company earned $278.60 million during the quarter, compared to analyst estimates of $265.60 million. Ingevity had a return on equity of 53.15% and a net margin of 14.92%. Ingevity's revenue was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.45 earnings per share. View Ingevity's Earnings History. When is Ingevity's next earnings date? Ingevity is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for Ingevity. What guidance has Ingevity issued on next quarter's earnings? Ingevity issued an update on its FY19 earnings guidance on Wednesday, February, 13th. The company provided earnings per share (EPS) guidance of ~5.16 for the period, compared to the Thomson Reuters consensus estimate of $4.71. The company issued revenue guidance of $1.3-1.36 billion, compared to the consensus revenue estimate of $1.23 billion.Ingevity also updated its FY 2019 guidance to EPS. What price target have analysts set for NGVT? 8 Wall Street analysts have issued 12 month price targets for Ingevity's stock. Their forecasts range from $68.00 to $110.00. On average, they expect Ingevity's share price to reach $97.25 in the next twelve months. This suggests that the stock has a possible downside of 14.9%. View Analyst Price Targets for Ingevity. What is the consensus analysts' recommendation for Ingevity? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity. Has Ingevity been receiving favorable news coverage? Media coverage about NGVT stock has trended somewhat positive on Friday, according to InfoTrie. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Ingevity earned a news sentiment score of 1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an effect on the stock's share price in the next few days. Who are some of Ingevity's key competitors? Some companies that are related to Ingevity include Koninklijke DSM (RDSMY), ASAHI KASEI COR/ADR (AHKSY), FMC (FMC), Johnson Matthey (JMPLY), Chemours (CC), Huntsman (HUN), W. R. Grace & Co (GRA), Ashland Global (ASH), KURARAY CO LTD/ADR (KURRY), Olin (OLN), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), Innospec (IOSP) and GCP Applied Technologies (GCP). What other stocks do shareholders of Ingevity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include General Electric (GE), Citigroup (C), Verizon Communications (VZ), Celgene (CELG), NVIDIA (NVDA), Dominion Energy (D), Pfizer (PFE), CVS Health (CVS), Quaker Chemical (KWR) and AbbVie (ABBV). Who are Ingevity's key executives? Ingevity's management team includes the folowing people: Mr. D. Michael Wilson, Pres, CEO & Director (Age 56)Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 52)Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 61)Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 53)Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 58) Who are Ingevity's major shareholders? Ingevity's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.43%), Massachusetts Financial Services Co. MA (1.81%), Channing Capital Management LLC (1.73%), Bank of New York Mellon Corp (1.51%), Northern Trust Corp (1.35%) and Dimensional Fund Advisors LP (1.29%). View Institutional Ownership Trends for Ingevity. Which institutional investors are selling Ingevity stock? NGVT stock was sold by a variety of institutional investors in the last quarter, including Castleark Management LLC, Copper Rock Capital Partners LLC, Kornitzer Capital Management Inc. KS, Mesirow Financial Investment Management Equity Management, Two Sigma Advisers LP, London Co. of Virginia, BlackRock Inc. and Barclays PLC. View Insider Buying and Selling for Ingevity. Which institutional investors are buying Ingevity stock? NGVT stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Braun Stacey Associates Inc., Massachusetts Financial Services Co. MA, Dimensional Fund Advisors LP, Channing Capital Management LLC, Nuveen Asset Management LLC, SG Americas Securities LLC and Geode Capital Management LLC. View Insider Buying and Selling for Ingevity. How do I buy shares of Ingevity? Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Ingevity's stock price today? One share of NGVT stock can currently be purchased for approximately $114.32. How big of a company is Ingevity? Ingevity has a market capitalization of $4.80 billion and generates $1.13 billion in revenue each year. The company earns $169.10 million in net income (profit) each year or $4.13 on an earnings per share basis. Ingevity employs 1,500 workers across the globe. What is Ingevity's official website? The official website for Ingevity is http://www.ingevity.com. How can I contact Ingevity? Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected] MarketBeat Community Rating for Ingevity (NYSE NGVT)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 246 (Vote Outperform)Underperform Votes: 227 (Vote Underperform)Total Votes: 473MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/22/2019 by MarketBeat.com StaffFeatured Article: How is net asset value different from market price?